AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest

Zinger Key Points
  • AdvisorShares MSOS ETF gained 8.17%, breaking above key moving averages as US cannabis reforms drive market momentum.
  • Indicators show near overbought conditions and increased volatility - investors should monitor potential short-term pull.

As the U.S. cannabis industry expects significant regulatory changes, AdvisorShares, a leading provider of cannabis-focused Exchange-Traded Funds (ETFs), shared the company’s view regarding the near future.

Managing over $1 billion in assets, the company's ETFs offer targeted exposure to U.S. multi-state operators (MSOs), providing opportunities for exposure to a market that’s been quite a rollercoaster ride over the last several years but might finally find some ground for sustainable growth.

“Cannabis continues to gain mainstream acceptance,” Dan Ahrens, managing director at AdvisorShares, said in a recent statement. “And we believe elections and reforms are setting the stage for growth.”

AdvisorShares offers three investment funds: the flagship ETF, MSOS MSOS, focuses on U.S. cannabis companies, while MSOX MSOX, designed for more experienced traders, offers leveraged exposure. 

YOLO YOLO blends U.S. cannabis exposure with global equities.

  • Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you’re serious about the business.

Among the referred key changes, the trust fund managers address the potential rescheduling of cannabis from Schedule I to Schedule III, which would significantly reduce tax burdens for U.S. cannabis operators. Also, increasing public support is mentioned, with over 92% of more than 43,000 public comments during the DEA hearing process favoring rescheduling.

In the upcoming elections, state ballot initiatives, particularly in Florida, Nebraska and North Dakota, are expected to further boost the market. Florida, where medical marijuana sales top $2 billion, could approve adult-use legalization, expanding the market to $5 billion annually.

Read Also: Is Utah Ready For Legal Weed? Half The State Says Yes – What’s The Market Potential?

MSOS Stock Surges On Bullish Momentum

This release had an impact on MSOS performance Tuesday. The MSOS ETF saw a sharp rise, closing at $7.68 after an 8.17% increase.

It broke above both the 8-day and 20-day simple moving averages, signaling strong upward momentum. The MACD shows positive movement with a reading of 0.09, while the RSI of 66.21 nears overbought territory, indicating the potential for a short-term pullback.

Chart created using Benzinga Pro

However, other indicators like Bollinger Bands show MSOS trading near the upper band, suggesting increased volatility. While bullish indicators remain, investors should watch for possible consolidation in the short term.

Chart created using Benzinga Pro

Cover: AI generated image

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisEquitiesNewsSector ETFsMarketsETFsBenzinga ProETFs CannabisETSMSOsMSOXstocksYOLO
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.